allantoin has been researched along with Multiple Myeloma in 2 studies
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ribatti, D | 1 |
| De Falco, G | 1 |
| Nico, B | 1 |
| Ria, R | 1 |
| Crivellato, E | 1 |
| Vacca, A | 1 |
| Wu, XH | 1 |
| Zhou, HJ | 1 |
| Lee, J | 1 |
2 other studies available for allantoin and Multiple Myeloma
| Article | Year |
|---|---|
In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane.
Topics: Allantoin; Animals; Chick Embryo; Chorion; Coculture Techniques; Endothelium, Vascular; Humans; Mult | 2003 |
Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.
Topics: Allantoin; Angiogenesis Inhibitors; Animals; Artemisinins; Blotting, Western; Cell Line, Tumor; Cell | 2006 |